First-line pemetrexed plus cisplatin followed by gefitinib maintenance therapy versus gefitinib monotherapy in East Asian patients with locally advanced or metastatic non-squamous non-small cell lung cancer: A randomised, phase 3 trial

Authors:

Abstract
No abstract available
Funding Information
  • Eli Lilly and Company

This publication has 24 references indexed in Scilit: